226 related articles for article (PubMed ID: 28576832)
1. EET intervention on Wnt1, NOV, and HO-1 signaling prevents obesity-induced cardiomyopathy in obese mice.
Cao J; Singh SP; McClung JA; Joseph G; Vanella L; Barbagallo I; Jiang H; Falck JR; Arad M; Shapiro JI; Abraham NG
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H368-H380. PubMed ID: 28576832
[TBL] [Abstract][Full Text] [Related]
2. EET enhances renal function in obese mice resulting in restoration of HO-1-Mfn1/2 signaling, and decrease in hypertension through inhibition of sodium chloride co-transporter.
Schragenheim J; Bellner L; Cao J; Singh SP; Bamshad D; McClung JA; Maayan O; Meissner A; Grant I; Stier CT; Abraham NG
Prostaglandins Other Lipid Mediat; 2018 Jul; 137():30-39. PubMed ID: 29787809
[TBL] [Abstract][Full Text] [Related]
3. Epoxyeicosatrienoic Acids Regulate Adipocyte Differentiation of Mouse 3T3 Cells, Via PGC-1α Activation, Which Is Required for HO-1 Expression and Increased Mitochondrial Function.
Waldman M; Bellner L; Vanella L; Schragenheim J; Sodhi K; Singh SP; Lin D; Lakhkar A; Li J; Hochhauser E; Arad M; Darzynkiewicz Z; Kappas A; Abraham NG
Stem Cells Dev; 2016 Jul; 25(14):1084-94. PubMed ID: 27224420
[TBL] [Abstract][Full Text] [Related]
4. CYP-450 Epoxygenase Derived Epoxyeicosatrienoic Acid Contribute To Reversal of Heart Failure in Obesity-Induced Diabetic Cardiomyopathy
Singh SP; McClung JA; Bellner L; Cao J; Waldman M; Schragenheim J; Arad M; Hochhauser E; Falck JR; Weingarten JA; Peterson SJ; Abraham NG
Cardiovasc Pharm Open Access; 2018; 7(1):. PubMed ID: 29707604
[TBL] [Abstract][Full Text] [Related]
5. Agonists of epoxyeicosatrienoic acids reduce infarct size and ameliorate cardiac dysfunction via activation of HO-1 and Wnt1 canonical pathway.
Cao J; Tsenovoy PL; Thompson EA; Falck JR; Touchon R; Sodhi K; Rezzani R; Shapiro JI; Abraham NG
Prostaglandins Other Lipid Mediat; 2015; 116-117():76-86. PubMed ID: 25677507
[TBL] [Abstract][Full Text] [Related]
6. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
[TBL] [Abstract][Full Text] [Related]
7. PGC-1 alpha regulates HO-1 expression, mitochondrial dynamics and biogenesis: Role of epoxyeicosatrienoic acid.
Singh SP; Schragenheim J; Cao J; Falck JR; Abraham NG; Bellner L
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():8-18. PubMed ID: 27418542
[TBL] [Abstract][Full Text] [Related]
8. Silencing the Adipocytokine NOV: A Novel Approach to Reversing Oxidative Stress-Induced Cardiometabolic Dysfunction.
Waldman M; Singh SP; Shen HH; Alex R; Rezzani R; Favero G; Hochhauser E; Kornowski R; Arad M; Peterson SJ
Cells; 2022 Sep; 11(19):. PubMed ID: 36231029
[TBL] [Abstract][Full Text] [Related]
9. Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in PGC1α-HO-1-PGC1α-mitochondrial signaling.
Raffaele M; Bellner L; Singh SP; Favero G; Rezzani R; Rodella LF; Falck JR; Abraham NG; Vanella L
Exp Cell Res; 2019 Jul; 380(2):180-187. PubMed ID: 31039348
[TBL] [Abstract][Full Text] [Related]
10. Ablation of soluble epoxide hydrolase reprogram white fat to beige-like fat through an increase in mitochondrial integrity, HO-1-adiponectin in vitro and in vivo.
Liu L; Puri N; Raffaele M; Schragenheim J; Singh SP; Bradbury JA; Bellner L; Vanella L; Zeldin DC; Cao J; Abraham NG
Prostaglandins Other Lipid Mediat; 2018 Sep; 138():1-8. PubMed ID: 30041041
[TBL] [Abstract][Full Text] [Related]
11. Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.
McClung JA; Levy L; Garcia V; Stec DE; Peterson SJ; Abraham NG
Pharmacol Ther; 2022 Mar; 231():107975. PubMed ID: 34499923
[TBL] [Abstract][Full Text] [Related]
12. Ablation of adipose-HO-1 expression increases white fat over beige fat through inhibition of mitochondrial fusion and of PGC1α in female mice.
Singh SP; Grant I; Meissner A; Kappas A; Abraham NG
Horm Mol Biol Clin Investig; 2017 Aug; 31(1):. PubMed ID: 28763300
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of PGC-1
Singh SP; Bellner L; Vanella L; Cao J; Falck JR; Kappas A; Abraham NG
J Nutr Metab; 2016; 2016():9039754. PubMed ID: 28097021
[No Abstract] [Full Text] [Related]
14. Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving 'SIRT1 and PGC-1α'.
Waldman M; Cohen K; Yadin D; Nudelman V; Gorfil D; Laniado-Schwartzman M; Kornwoski R; Aravot D; Abraham NG; Arad M; Hochhauser E
Cardiovasc Diabetol; 2018 Aug; 17(1):111. PubMed ID: 30071860
[TBL] [Abstract][Full Text] [Related]
15. Improved endogenous epoxyeicosatrienoic acid production mends heart function via increased PGC 1α-mitochondrial functions in metabolic syndrome.
Liu L; Huang X; Gao J; Guo Y; Di Y; Sun S; Deng X; Cao J
J Pharmacol Sci; 2018 Oct; 138(2):138-145. PubMed ID: 30342783
[TBL] [Abstract][Full Text] [Related]
16. Wnt/β-Catenin Antagonist Pyrvinium Exerts Cardioprotective Effects in Polymicrobial Sepsis Model by Attenuating Calcium Dyshomeostasis and Mitochondrial Dysfunction.
Sen P; Gupta K; Kumari A; Singh G; Pandey S; Singh R
Cardiovasc Toxicol; 2021 Jul; 21(7):517-532. PubMed ID: 33723718
[TBL] [Abstract][Full Text] [Related]
17. Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice.
Sodhi K; Inoue K; Gotlinger KH; Canestraro M; Vanella L; Kim DH; Manthati VL; Koduru SR; Falck JR; Schwartzman ML; Abraham NG
J Pharmacol Exp Ther; 2009 Dec; 331(3):906-16. PubMed ID: 19717790
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial aldehyde dehydrogenase obliterates insulin resistance-induced cardiac dysfunction through deacetylation of PGC-1α.
Hu N; Ren J; Zhang Y
Oncotarget; 2016 Nov; 7(47):76398-76414. PubMed ID: 27634872
[TBL] [Abstract][Full Text] [Related]
19. EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels.
Sodhi K; Puri N; Inoue K; Falck JR; Schwartzman ML; Abraham NG
Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):133-42. PubMed ID: 22209722
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin ameliorates iron-overload cardiomyopathy through the PPARα-PGC-1-dependent signaling pathway.
Lin H; Lian WS; Chen HH; Lai PF; Cheng CF
Mol Pharmacol; 2013 Aug; 84(2):275-85. PubMed ID: 23723143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
